Dual 5-HT2/alpha1-adrenoceptor antagonists for treating cardiovascular disorders Aug. 6, 1999 No Comments
GenVec gene therapy shows promising phase I results in patients with severe coronary artery disease Aug. 6, 1999 No Comments
ROCK inhibitor Y-27632 affects ET-1-induced hypertrophy in rat cardiac myocytes Aug. 5, 1999 No Comments
Fujisawa and Discovery Therapeutics enter agreement for cardiovascular drug development Aug. 4, 1999 No Comments
Third-generation beta-blocker with vasorelaxant and alpha-adrenoceptor-blocking effects July 30, 1999 No Comments
Inhibitors of 15-LO designed at Warner-Lambert, particularly useful for atherosclerosis July 30, 1999 No Comments